OGEN · Forms 3, 4, 5
Insider trades at ORAGENICS INC
No open-market insider buys or sells at ORAGENICS INC in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for ORAGENICS INC (OGEN) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for ORAGENICS INC in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| John Spencer | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| John Spencer | Chief Financial Officer | Became an insider (Form 3) | Form 3 | ||||
| Janet Huffman | CEO and CFO | Options or other derivatives | Form 4 | ||||
| Natasha Giordano | Director | Options or other derivatives | Form 4 | ||||
| John P Gandolfo | Director | Options or other derivatives | Form 4 | ||||
| Alan W Dunton | Director | Options or other derivatives | Form 4 | ||||
| Robert C Koski | Director | Options or other derivatives | Form 4 | ||||
| Charles L Pope | Director | Options or other derivatives | Form 4 | ||||
| Fred Telling | Director | Sell | 210 | $0.94 | $198 | Form 4 | |
| Natasha Giordano | Director | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.